Slentrol

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide
MedicineVeterinaryWithdrawn

Danish is available via eTranslation, the European Commission's machine translation service.

Translate to Danish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 KB - PDF)

Vis

español (ES) (239.85 KB - PDF)

Vis

čeština (CS) (283.94 KB - PDF)

Vis

dansk (DA) (239 KB - PDF)

Vis

Deutsch (DE) (241.8 KB - PDF)

Vis

eesti (ET) (237.14 KB - PDF)

Vis

ελληνικά (EL) (282.67 KB - PDF)

Vis

français (FR) (245.68 KB - PDF)

Vis

italiano (IT) (238.08 KB - PDF)

Vis

latviešu (LV) (283.06 KB - PDF)

Vis

lietuvių (LT) (251.47 KB - PDF)

Vis

magyar (HU) (253.42 KB - PDF)

Vis

Malti (MT) (265.77 KB - PDF)

Vis

Nederlands (NL) (217.72 KB - PDF)

Vis

polski (PL) (282.55 KB - PDF)

Vis

português (PT) (218.29 KB - PDF)

Vis

română (RO) (242.81 KB - PDF)

Vis

slovenčina (SK) (260.4 KB - PDF)

Vis

slovenščina (SL) (252.65 KB - PDF)

Vis

suomi (FI) (237.94 KB - PDF)

Vis

svenska (SV) (239.22 KB - PDF)

Vis

Product information

български (BG) (1.12 MB - PDF)

Vis

español (ES) (413.23 KB - PDF)

Vis

čeština (CS) (559.01 KB - PDF)

Vis

dansk (DA) (619.26 KB - PDF)

Vis

Deutsch (DE) (409.78 KB - PDF)

Vis

eesti (ET) (394.94 KB - PDF)

Vis

ελληνικά (EL) (1.78 MB - PDF)

Vis

français (FR) (455.26 KB - PDF)

Vis

italiano (IT) (432.39 KB - PDF)

Vis

latviešu (LV) (543.86 KB - PDF)

Vis

lietuvių (LT) (475.04 KB - PDF)

Vis

magyar (HU) (577.53 KB - PDF)

Vis

Malti (MT) (631.26 KB - PDF)

Vis

Nederlands (NL) (419.67 KB - PDF)

Vis

polski (PL) (601.64 KB - PDF)

Vis

português (PT) (402.62 KB - PDF)

Vis

română (RO) (490.98 KB - PDF)

Vis

slovenčina (SK) (616.03 KB - PDF)

Vis

slovenščina (SL) (568.91 KB - PDF)

Vis

suomi (FI) (408.3 KB - PDF)

Vis

svenska (SV) (413.86 KB - PDF)

Vis

Íslenska (IS) (418.64 KB - PDF)

Vis

norsk (NO) (405.73 KB - PDF)

Vis
Latest procedure affecting product information:IAIN/0007/G
15/01/2015

български (BG) (202.54 KB - PDF)

Vis

español (ES) (148.22 KB - PDF)

Vis

čeština (CS) (192.56 KB - PDF)

Vis

dansk (DA) (151.57 KB - PDF)

Vis

Deutsch (DE) (152.17 KB - PDF)

Vis

eesti (ET) (147.88 KB - PDF)

Vis

ελληνικά (EL) (200.73 KB - PDF)

Vis

français (FR) (474.14 KB - PDF)

Vis

italiano (IT) (148.51 KB - PDF)

Vis

latviešu (LV) (202.11 KB - PDF)

Vis

lietuvių (LT) (191.42 KB - PDF)

Vis

magyar (HU) (188.69 KB - PDF)

Vis

Malti (MT) (194.75 KB - PDF)

Vis

Nederlands (NL) (151.46 KB - PDF)

Vis

polski (PL) (176.01 KB - PDF)

Vis

português (PT) (151.81 KB - PDF)

Vis

română (RO) (188.05 KB - PDF)

Vis

slovenčina (SK) (195.92 KB - PDF)

Vis

slovenščina (SL) (189.87 KB - PDF)

Vis

suomi (FI) (147.96 KB - PDF)

Vis

svenska (SV) (151.54 KB - PDF)

Vis

Íslenska (IS) (151.76 KB - PDF)

Vis

norsk (NO) (148.31 KB - PDF)

Vis

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page